'Healthy' everyday foods that could increase your risk of one type of cancer
A host of 'healthy' everyday foods could increase your risk of one type of cancer, according to doctors.
Yoghurts and post-workout protein shakes are among the many supermarket products that contain emulsifiers, additives which are used to hold ingredients together and create a consistent texture. While their presence in foods tends to go unnoticed by most consumers, scientists have begun to pay more attention in recent years to the effects they can have on gut health. It is thought many common emulsifiers could weaken the protective layer of mucus lining the gut, allowing harmful bacteria to multiply.
This in turn can lead to chronic inflammation - a common trigger for bowel cancer, also known as colorectal cancer or colon cancer in the US.
It follows an uptick in this form of cancer among young people, with an American Cancer Society-led research team finding increasing rates in younger adults in 27 out of the 50 countries they studied - including the UK.
Dr Maria Abreu, president of the American Gastroenterological Association, told the DailyMail.com: "'One of the things that has changed very dramatically in our food supply is the addition of emulsifiers.
"Chronic inflammation leads to colon cancer, and I suspect that's transformative in this new rise of young people developing colon cancer."
Kids' treats such as peanut butters are among the foods high in emulsifiers such as mono and diglycerides, which are designed to stop oil and nut spread from separating inside the jar.
But a 2024 PLOS Medicine study that tracked 92,000 adults for seven years found that participants who admitted often consuming foods with high levels of these had as much as a 46% increased risk of developing breast or prostate cancer.
Protein shakes often contain an emulsifier made from red seaweed known as carrageenan, which has been found in multiple studies to potentially contribute to tumour growth in animals.
Packs of cheese meanwhile contain cellulose gum, which is used to stop it from sticking together.
A 2015 study on mice funded by the US National Institutes of Health found that this altered gut bacteria, triggered inflammation and led to increased cases of bowel cancer.
Bread, chocolate, cakes, ice cream, margarine and processed meats also contain different types of emulsifiers.
While there is a growing field of study into a possible link between emulsifiers and damage to the gut, this has not yet been definitively proven, and he Food Standards Agency (FSA) in the UK currently considers them safe for consumption.
The FSA's webpage on additives - which also include antioxidants, colourings, gelling agents, preservatives and sweeteners - says they are "strictly reviewed" and that "action is taken where problems are found".
According to the NHS, the main symptoms of bowel cancer include noticeable changes in bowel habits, such as looser stools, frequent diarrhoea or constipation. Other signs are blood in your poo, which may look red or black, and unexplained abdominal pain, bloating or discomfort. Some people may feel a lump in their tummy, or experience unexplained weight loss and extreme tiredness.
If you notice any of these symptoms for three weeks or more, you should see a GP.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
6 hours ago
- Daily Mail
Doctors discover food that prevents heart disease and diabetes... and 90% of Americans don't eat enough of it
Regularly eating a combination of fruits, vegetables, nuts and whole grains may reduce your risk of developing two of the most deadly chronic diseases, a study suggests. A group of American researchers discovered phytosterols, a compound found naturally in a variety of foods like nuts, seeds, grains and vegetable oils, can help improve metabolism and reduce inflammation - keeping both heart disease and type 2 diabetes at bay. However, up to 90 percent of Americans don't eat the recommended daily serving of fruits, vegetables, nuts and whole grains. Phytosterols are compounds similar to cholesterol and are promoted as a way to improve heart health and decrease blood levels of LDL (bad) cholesterol as they are known to absorb the fat-like substance. Now, the new study suggests high phytosterol intake can also improve insulin regulation, reduce heart inflammation and contribute to a healthy metabolism. Type 2 diabetes is the most common form of diabetes globally and over 37million American adults suffer from it. The American Heart Association reports about 48 percent of Americans are living with some type of cardiovascular disease and CVD is the number one killer in the US - accounting for about one in five deaths. Dr Fenglei Wang, lead author and research associate at Harvard University, said the findings support claims that eating a healthy plant-based diet with plenty of vegetables and whole grains can be beneficial for humans. While phytosterols are found in all plant foods, the highest concentrations are found in unrefined plant oils, including vegetable, nuts and olive oils. Nuts such as almonds, pistachio and cashews; seeds such as pumpkin, sunflower and watermelon; whole grains such as oats and barley as well as legumes such as chickpeas, lentils and soybeans are also good dietary sources of phytosterols. The compound is also found in vegetables such as artichokes, broccoli, green beans, sweet potatoes and cauliflower as well as fruits such as pineapples, oranges, berries and bananas. The researchers followed over 200,000 American adults for 36 years. The participants were asked to periodically answer questionnaires on dietary intake to measure how much phytosterol-rich food they were consuming. Their answers were then evaluated using a variety of statistical models to discover their likelihood of developing Type 2 diabetes and heart disease. During the follow-up period, the researchers noted over 20,000 study participants developed Type 2 diabetes and nearly 16,000 developed heart disease. Results showed those who consumed about five servings of vegetables, three servings of fruit, two servings of whole grains and half a serving of nuts - all of which are high in phytosterols - per day were about 10 percent less likely to develop either conditions. But nearly no American reaches these benchmarks. The researchers also analyzed metabolites - products of metabolism - and other metabolic biomarkers present in blood samples from about 40,000 people to understand the effect of phytosterols on the calorie-burning process. They discovered those who consumed phytosterols had better metabolism - which helped control insulin levels and inflammation around the heart. Dr Wang noted the results showed consuming phytosterols may reduce the risk for Type 2 diabetes by reducing insulin resistance in the body and stave off heart disease by preventing inflammation. The foods studied as part of the research are recommended as part of a healthy and well-rounded diet and have been linked to multiple health benefits also because of their antioxidants and fiber. The scientists in the most recent study, however, did not specify how they observed the benefits stemmed from the consumption of phytosterols specifically. The study was presented today at the Bioactives for Brain and Cardiometabolic Health session in Orange County, Florida and will later be published in the journal Nutrition.
NBC News
7 hours ago
- NBC News
Wegovy use among U.S. teens up 50% as obesity crisis worsens
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug grew 50% last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. That's up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children aged 12 and older. The average rate climbed further during the first three months of this year, reaching 17.3 new prescriptions per 100,000. That still represents a minute fraction of the estimated 23,000 out of every 100,000 teens in the country who are living with obesity, and is far slower than the uptake among U.S. adults. 'It's promising that more young people are using these medications, but it's still a very small percentage of patients with severe obesity that are getting access to them,' said Dr. Cate Varney, director of obesity medicine at the University of Virginia Health system. 'When lifestyle changes alone are insufficient, we need these additional tools.' For its analysis, Truveta reviewed the electronic health records of 1.3 million patients ages 12 through 17. The data covers 30 U.S. health systems with more than 900 hospitals and 20,000 clinics across the country. The analysis did not include other GLP-1 drugs, including Novo's Ozempic and Eli Lilly's LLY.N Zepbound, which are not approved to treat obesity in adolescents, or compounded versions of these therapies. Wegovy became an option to treat adolescents in late 2022 after decades in which the conventional approaches of diet, exercise and counseling largely failed. About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S. government data. Young people with obesity run a much higher risk of developing chronic, costly, life-shortening conditions like type 2 diabetes and cardiovascular and liver diseases. In January 2023, the American Academy of Pediatrics strongly recommended that doctors provide weight-loss drugs to children with obesity starting at age 12. Yet the medical community has not uniformly embraced GLP-1s for adolescents. Some doctors are hesitant because the drugs' long-term safety for children during a critical phase of development is unknown, and the treatments may need to be used indefinitely. Overall, there are limited options for many teens and their parents because insurance plans often do not cover any treatment for obesity, including intensive behavioral counseling, visits with a dietician or the new GLP-1 medications. At Nemours Children's Hospital in Wilmington, Delaware, the Healthy Weight and Wellness Clinic treated about 2,000 adolescent patients last year. About 25% were prescribed Wegovy or another GLP-1 medication, said Dr. Thao-Ly Phan, the clinic's medical director. The number of adolescents with a GLP-1 prescription nearly doubled from 2023. On average, their patients taking a GLP-1 drug lost 15 pounds (6.8 kg) within 6 to 12 months, and nearly 30 pounds after more than a year. For many of the other patients, the medications were not an option, either because of insurance hurdles or concern within families about potential risks. Other teens opted for lifestyle changes or older, cheaper weight-loss drugs, with some success. 'It is important for us to continue to monitor and better understand outcomes from the medications — both positive and negative — before widespread use,' Phan said. U.S. Health Secretary Robert F. Kennedy Jr. has criticized the idea of prescribing Ozempic or Wegovy widely to children to treat obesity. In a federal health report he released last month, GLP-1 drugs were cited as an example of the 'overmedicalization of our kids.' It noted a lack of 'long-term safety data, raising the specter of unforeseen problems that interrupt, damage, or impair metabolism and growth development.' Novo in a statement said semaglutide, the active ingredient in Wegovy and Ozempic, 'did not appear to affect growth or pubertal development' during its clinical trials involving teens. For many adults, Novo said, obesity starts in childhood or adolescence, and 'we are confident in the proven safety and efficacy of our GLP-1 medicines.' Eli Lilly's weight-loss drug Zepbound is in late-stage clinical trials for use by adolescents. Lilly told Reuters that 'there has been no evidence to date suggesting impairment in growth or metabolism' from GLP-1 medications. Dr. Robert Siegel, a pediatrician and director of the Center for Better Health and Nutrition at Cincinnati Children's Hospital, said about 15% of adolescents being treated there were prescribed Wegovy or a similar GLP-1 medication from July 2021 to July 2023. They include patients being treated for type 2 diabetes for which the GLP-1 drugs were originally developed. Siegel said he prefers to start teens on three to six months of intensive lifestyle management before even considering medication. While obesity specialists can help navigate potential risks from the drugs, many primary-care providers need more training, he said. They may not have the equipment to monitor for the loss of muscle mass — a side effect of these medicines — or lack the resources to work with families over an extended period on healthier eating and exercise. 'These medications are likely to be needed for a very long time to maintain weight,' Siegel said, 'and we only have a relatively short-term experience with them.'
Scottish Sun
7 hours ago
- Scottish Sun
Sleep problem that affects 10million people in UK could trigger world's deadliest cancer, first-of-its-kind study warns
Find out if you're at risk of the sleep problem below WAKE-UP CALL Sleep problem that affects 10million people in UK could trigger world's deadliest cancer, first-of-its-kind study warns HEAVY snorers could be at risk of the world's deadliest cancer, a shock new study has revealed. Obstructive sleep apnea (OSA) has previously been linked to an increased risk of certain cancers. Advertisement 1 Obstructive sleep apnoea has been specifically linked to lung cancer Credit: Getty Now, in a world-first trial, a "significant" link has been found between the condition and lung cancer. US researchers, who assessed the health records of more than 2.4 million adults, say they're not exactly sure why it raises the risk. But they believe it could be due to a lack of oxygen people with the condition get during the night - or lifestyle factors such as smoking and obesity. The findings were presented at the American Society of Clinical Oncology conference in Chicago. Advertisement Scientists present urged policymakers to consider screening those with OSA for the cancer, and to tackle the condition early, soon after diagnosis. Globally, an estimated 936 million adults aged 30-69 years are affected by OSA. The condition occurs when the muscles in the throat relax too much during sleep, causing the airway to narrow or close, interrupting breathing. This can happen due to several factors, including obesity, a large neck or collar size, structural abnormalities like a small lower jaw or a large tongue, and other medical conditions. Advertisement Common symptoms include breathing stopping and starting, making gasping, snorting or choking noises, waking up a lot, and loud snoring, says the NHS. According to the Sleep Apnoea Trust, as many as 10 million people in the UK suffer from OSA – with up to four million of these suffering either severely or moderately - although it's considered to be underdiagnosed. I'm a doctor and these 5 changes could be a sign of deadly lung cancer It's important to note while snoring is a common symptom of OSA, it's not a guaranteed sign. In the study, researchers at Marshall University in West Virginia tracked lung cancer diagnoses and separated those diagnosed with OSA and those without. Advertisement After accounting for different influential factors, such as age, people with OSA were found to be 1.21 times more likely to develop lung cancer compared to those without the sleep disorder. Dr Jowan Al-Nusair, study co-author and physician at Marshall University told MailOnline it was "one of the first statistically significant studies" to prove a link between the condition and lung cancer. She added: "While further studies are definitely now needed to investigate just how the significant the link truly is, this suggests OSA may be a preventable risk factor for lung cancer. "We should be more closely monitoring patients with OSA. Patients would definitely benefit from screening and early intervention to combat OSA. Advertisement "Additional studies are essential to understand exactly why OSA may increase this risk. "We really hope this will pave the way for future research and testing." Lung cancer is the leading cause of cancer deaths worldwide. In the UK, around 35,000 people die from lung cancer each year. Advertisement The primary cause of lung cancer is tobacco smoke, accounting for the vast majority of cases. But lung cancer cases are now rising among young people who have never smoked, with some experts attributing this to factors like air pollution.
